Europe healthcare markets

• 178Market reports
• 146With size & growth
• 42Markets with active clinical trials
• 12+Key companies named

Health in Europe: WHO figures

Europe: People and health spending

Companies most covered in Europe

All 178 Europe markets

Each market name opens its Europe report. To compare one market across every country, see market statistics.

Digital Health 41 markets

Digital Health markets in Europe

Market	2023	2033 (projected)	CAGR	Active trials
3D Laparoscopy Imaging Systems	$608 Mn	$1 Bn	5.4%	8
3D Printed Implants	$684 Mn	$2.2 Bn	12.2%	17
3D Printing in Medical Application	$456 Mn	$2.6 Bn	19%	41
Artificial Intelligence (AI) in Drugs Discovery	$114 Mn	$1 Bn	24.8%	130
Artificial Intelligence (AI) in Healthcare	–	–	–	652
Artificial Intelligence (AI) in Life Sciences	$418 Mn	$4 Bn	25.4%	456
Artificial Intelligence (AI) in Medical Imaging	$171 Mn	$1.5 Bn	23.9%	168
Artificial Intelligence (AI) in Medicine	$1.6 Bn	$34.7 Bn	36.2%	652
Artificial Intelligence (AI) in Pharma	–	–	–	130
Artificial Intelligence (AI) in Radiology	$114 Mn	$1.3 Bn	27.3%	34
Artificial Intelligence (AI) in Remote Patient Monitoring	$171 Mn	$2.2 Bn	29.1%	31
Artificial Intelligence (AI) Machine Learning(ML) in Healthcare	$361 Mn	$8.3 Bn	36.7%	652
Blockchain in Genomics	$424 Mn	$9.9 Bn	37%	0
Blockchain-as-a-Service	$399 Mn	$4.7 Bn	28%	0
Brain Imaging, Biomarkers and NeuroInformatics	$129 Mn	$181 Mn	3.4%	906
Brain PET-MRI Systems	$65 Mn	$108 Mn	5.2%	272
Clinical Alarm Management	$331 Mn	$405 Mn	2%	39
Clinical Data Management Systems	$475 Mn	$1.3 Bn	10.6%	32
Connected Healthcare Market	$11.2 Bn	$111.3 Bn	25.8%	161
Decentralized Clinical Trials(DCTs)	$312 Mn	$1.1 Bn	13.5%	489
Dental 3D Printing	$644 Mn	$3.7 Bn	19.2%	8
Dental CAD/CAM	$631 Mn	$1.5 Bn	8.7%	14
Digital Biomarkers	$836 Mn	$15.9 Bn	34.2%	256
Digital diabetes care	$2.4 Bn	$12.8 Bn	18%	121
Digital Pathology Systems	$228 Mn	$736 Mn	12.4%	447
Digital Therapeutics	$1.3 Bn	$7.8 Bn	19.7%	933
Digital Twin	$323 Mn	$2.6 Bn	23%	17
Digital X-ray	$3.3 Bn	$5.2 Bn	4.5%	974
Electronic Health Record	$6.9 Bn	$9.2 Bn	2.9%	185
Healthcare Information System	$55.1 Bn	$239.9 Bn	15.8%	1,032
Healthcare IT	$91.7 Bn	$263.6 Bn	11.1%	196
Home Healthcare	$68.8 Bn	$130.9 Bn	6.6%	1,134
Internet Of Things In Healthcare	$18.9 Bn	$81.6 Bn	15.7%	5
IoT in Healthcare	$34.3 Bn	$149.3 Bn	15.8%	5
Long-term Care Software	$665 Mn	$1.9 Bn	11.3%	159
Mental Health Apps	$1.1 Bn	$6.3 Bn	19.4%	90
Pathology Imaging Systems	$308 Mn	$846 Mn	10.6%	447
Point of Care Diagnostics	$8.6 Bn	$15.7 Bn	6.1%	1,824
Remote Medication Management	$737 Mn	$3.2 Bn	15.7%	140
Remote Patient Monitoring	$300 Mn	$1.4 Bn	16.5%	239
Werable Healthcare Devices	$6.2 Bn	$34 Bn	18.5%	244

Healthcare Services 24 markets

Healthcare Services markets in Europe

Market	2023	2033 (projected)	CAGR	Active trials
Alopecia areata	–	–	–	25
Alzheimers Dignostic	$399 Mn	$691 Mn	5.6%	240
Ambulance Service	$5.9 Bn	$10.5 Bn	5.8%	273
Ambulatory Surgery Center	$7.6 Bn	$12.2 Bn	4.8%	2,818
Antimicrobial Susceptibility Testing	–	–	–	54
Bioinformatics	$2.3 Bn	$8 Bn	13.1%	–
Biomaterial Wound Dressing	$1.6 Bn	$2.6 Bn	5.4%	42
Blood Gas and Electrolyte Analyzers	$532 Mn	$878 Mn	5.1%	241
Bone Cancer Diagnostic	$209 Mn	$379 Mn	6.1%	270
Brain Cancer Diagnostic	$285 Mn	$912 Mn	12.3%	343
Breast Cancer Diagnostic	$779 Mn	$1.5 Bn	6.5%	868
Clinical Laboratory Service	–	–	–	–
Dental Care Service	–	–	–	–
Dental Imaging	$646 Mn	$1.2 Bn	6.6%	–
Dermatology Diagnostic	$4.9 Bn	$12.7 Bn	9.9%	1,016
Fertility Service	$4 Bn	$6.4 Bn	4.8%	–
Healthcare Electronic Data Interchange (EDI)	$760 Mn	$1.7 Bn	8.1%	25
Healthcare In Vitro Diagnostic	$15.9 Bn	$20.4 Bn	2.5%	152
Hospitals and Health Systems	$827.7 Bn	$1,265.9 Bn	4.3%	12,590
Medical Billing	$855 Mn	$2.2 Bn	10.1%	13
Medical Tourism	$14.1 Bn	$39.8 Bn	10.9%	2
Nursing Education	$2 Bn	$3.8 Bn	6.8%	82
Patient Support Programs (PSP)	$3.3 Bn	$9.7 Bn	14.5%	488
Point Of Care (PoC) Molecular Diagnostic	$3.6 Bn	$7.7 Bn	8%	111

Medical Devices 27 markets

Medical Devices markets in Europe

Market	2023	2033 (projected)	CAGR	Active trials
Acute Care Needleless Connectors	$93 Mn	$171 Mn	6.2%	–
Advanced Bipolar Direct Energy Devices	$589 Mn	$1.2 Bn	7.4%	–
Aesthetic Lasers and Energy Devices	$308 Mn	$862 Mn	10.8%	–
Air Ambulance Life Support Solutions	$849 Mn	$1.8 Bn	7.8%	–
Airway Management Devices	$380 Mn	$559 Mn	3.9%	–
Anastomosis Devices	$599 Mn	$1 Bn	5.5%	–
Anesthesia & Respiratory Devices	$5.5 Bn	$12 Bn	8.2%	–
Anesthesia Monitoring Devices	$502 Mn	$1.5 Bn	11.2%	–
Angiography Devices	$2.4 Bn	$3.9 Bn	5%	–
Angioplasty Balloons	$771 Mn	$991 Mn	2.5%	–
Anti-Snoring Devices	$238 Mn	$491 Mn	7.5%	–
Apheresis Equipments	$483 Mn	$782 Mn	4.9%	–
Arrhythmia Monitoring Devices	$1.1 Bn	$1.7 Bn	4.2%	–
Assisted Walking Aids	$437 Mn	$662 Mn	4.2%	–
Audiology Devices	$1.5 Bn	$2.5 Bn	5.1%	–
Defibrillator	$3.4 Bn	$5.3 Bn	4.6%	–
Dental Articulators	$74 Mn	$122 Mn	5.1%	–
Dental Caries Detectors	$70 Mn	$192 Mn	10.5%	–
Dental Diagnostic and Surgical Equipments	$2.3 Bn	$4 Bn	5.8%	–
Dental X-Ray Equipments	$333 Mn	$592 Mn	5.9%	–
Diabetes Care Devices	$8.1 Bn	$12.7 Bn	4.6%	–
Digital Diabetes Management	–	–	–	–
Direct Energy Medical Devices	$2.1 Bn	$3 Bn	3.7%	–
Disposable Surgical Devices	$1.7 Bn	$3.1 Bn	6%	–
Insulin Delivery Devices	$3 Bn	$5 Bn	5.2%	–
Insulin Patch Pumps	$169 Mn	$469 Mn	10.7%	–
Rehabilitation Equipments	$3.8 Bn	$6.1 Bn	4.8%	–

OTC & Nutraceuticals 48 markets

OTC & Nutraceuticals markets in Europe

Market	2023	2033 (projected)	CAGR	Active trials
Adaptogens	$1.5 Bn	$3.1 Bn	7.2%	–
Amino Acid	–	–	–	–
Anthelmintic Drug	–	–	–	–
Antioxidants	–	–	–	–
Antipyretics OTC	–	–	–	–
BCAA Supplement	$266 Mn	$452 Mn	5.4%	–
Beauty Supplements	$779 Mn	$1.7 Bn	7.9%	–
Biotin Supplement	$76 Mn	$110 Mn	3.7%	–
Bone & Joint Health Supplements	$2.3 Bn	$3.8 Bn	5.1%	–
Calcium Supplements	$475 Mn	$755 Mn	4.7%	–
Cannabidiol (CBD) Supplements	$1 Bn	$4.3 Bn	15.5%	–
Cardiovascular Health Supplements	$1.3 Bn	$2 Bn	4.4%	–
Clinical Nutrition	$5.4 Bn	$9.6 Bn	5.8%	–
Coenzyme Q10	$95 Mn	$200 Mn	7.7%	–
Collagen Supplements	$418 Mn	$671 Mn	4.8%	–
Creatine	$114 Mn	$186 Mn	5%	–
Dietary Supplements	$58.5 Bn	$94.8 Bn	4.9%	–
Eye Health Supplements	$589 Mn	$954 Mn	4.9%	–
Functional Food	$54.2 Bn	$92 Bn	5.4%	–
Hair Growth Supplements	$342 Mn	$615 Mn	6%	–
Herbal Supplements	$15.6 Bn	$28.8 Bn	6.3%	–
Immune Health Supplement	–	–	–	–
Iron Supplement	$380 Mn	$633 Mn	5.2%	–
Men's Health Supplements	$3.4 Bn	$5.9 Bn	5.5%	–
Mood and Stress Supplements	$2 Bn	$3.9 Bn	6.8%	–
Nutritional Supplements	$73.2 Bn	$125.4 Bn	5.5%	–
Omega 3 Fatty Acid	$779 Mn	$1.4 Bn	6.1%	–
Oncology Nutrition	$399 Mn	$717 Mn	6%	–
Osteoporosis Supplements	$589 Mn	$982 Mn	5.2%	–
Over The Counter (OTC) Analgesics	$4.2 Bn	$5.2 Bn	2.1%	–
Over The Counter (OTC) Antifungal	$475 Mn	$610 Mn	2.5%	–
Over The Counter (OTC) Consumer	$28.7 Bn	$42.2 Bn	3.9%	–
Over The Counter (OTC) Drugs	$33.8 Bn	$47.4 Bn	3.4%	–
Over The Counter (OTC) Gastrointestinal Drugs	$1.1 Bn	$1.4 Bn	2.6%	–
Over The Counter (OTC) Medications for Cough, Cold & Flu Drugs	$2.8 Bn	$3.6 Bn	2.8%	–
Over The Counter (OTC) Ophthalmic Drugs	$684 Mn	$941 Mn	3.2%	–
Over The Counter (OTC) Pharmaceuticals	$33.8 Bn	$47.4 Bn	3.4%	–
Over The Counter (OTC) Sleep Aid Products	$1 Bn	$1.3 Bn	2.7%	–
Over The Counter (OTC) Vitamins and Minerals	$6.1 Bn	$9.2 Bn	4.2%	–
Plant-Based Supplements	$2.3 Bn	$4.5 Bn	6.7%	–
Prebiotics	$1.5 Bn	$4.2 Bn	10.5%	–
Probiotic Supplements for Gut Health	$1.2 Bn	$2.1 Bn	5.9%	–
Protein Supplement	$3.8 Bn	$6.9 Bn	6.1%	–
Sports Nutrition	$9.9 Bn	$18.8 Bn	6.6%	–
Vitamin B12(Cobalamin)	$57 Mn	$86 Mn	4.2%	–
Vitamin D Supplements	–	–	–	–
Weight Management Supplement	–	–	–	–
Women's Health Supplements	$3.8 Bn	$6.5 Bn	5.5%	–

Pharmaceuticals 38 markets

Pharmaceuticals markets in Europe

Market	2023	2033 (projected)	CAGR	Active trials
Abuse Deterrent Opioids	–	–	–	–
Alexipharmic Drugs	–	–	–	–
Alopecia Drugs (Hair Loss)	–	–	–	–
Alzheimer Drugs	$952 Mn	$1.6 Bn	5.5%	–
Aminoglycosides	–	–	–	–
Anemia Drugs	–	–	–	–
Anti-Aging	$16.8 Bn	$32.5 Bn	6.8%	–
Anti-Depressants Drugs	$3.4 Bn	$3.9 Bn	1.4%	–
Anti-Nerve Growth Factor	–	–	–	–
Anti-Venom	–	–	–	–
Anticoagulants	–	–	–	–
Antithrombotic Drugs	–	–	–	–
Artificial Skin	$475 Mn	$741 Mn	4.5%	–
Asthma & COPD Drugs	$9.4 Bn	$12.3 Bn	2.7%	–
Atherosclerosis Drugs	–	–	–	–
Atopic Dermatitis Drugs	$2.1 Bn	$6 Bn	10.9%	–
Autologous Matrix-induced Chondrogenesis	–	–	–	–
Axial Spondyloarthritis (axSpA)	–	–	–	–
Biological Safety Testing	–	–	–	–
Biosimilar Monoclonal Antibodies	–	–	–	–
Biosimilars	$7 Bn	$58.5 Bn	23.6%	–
Blood Plasma	–	–	–	–
Bone Marrow Aspirate Concentrates	–	–	–	–
Burn Care	–	–	–	–
Burn Ointment	–	–	–	–
Cancer Supportive Care Drugs	$4.7 Bn	$6.6 Bn	3.4%	–
Cannabidiol (CBD)	$4.2 Bn	$17.8 Bn	15.5%	–
Cannabis	$6.4 Bn	$20.4 Bn	12.2%	–
Cell Based Immunotherapy	$3.2 Bn	$22.6 Bn	21.7%	–
Contraceptives Drugs	$4.8 Bn	$8.2 Bn	5.5%	–
Cord Blood Banking Service	$361 Mn	$602 Mn	5.2%	–
Diabetes Management	$14.8 Bn	$26.1 Bn	5.8%	–
Diabetic Retinopathy Drugs	$2.1 Bn	$3.3 Bn	4.7%	–
Epilepsy Drugs	$1.8 Bn	$2.3 Bn	2.2%	–
Gastroesophageal Reflux Disease (GERD) Drugs	$988 Mn	$1.1 Bn	0.8%	–
Gastrointestinal Drugs	$10.3 Bn	$14.3 Bn	3.3%	–
HIV Drugs	$5.7 Bn	$8.9 Bn	4.5%	–
Oncology/Cancer Drugs	$33.6 Bn	$67 Bn	7.1%	–

"–" means we have no size for that market here yet. Values for 2033 are projected from the 2023 size and the CAGR.

Sources: market sizes and growth: Acuitas Health Analytics research. Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide, and one trial can count in more than one market. Health figures: WHO Global Health Observatory. People and health spending: World Bank. Public figures fetched 10 Nov 2026.

All 178 Europe reports Other countries